ANDA 88232, held by Duramed Pharms Barr. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 88232 (Cyproheptadine Hydrochloride), held by Duramed Pharms Barr, was first approved by FDA on Oct 25, 1983, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 25, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride4MG ยท tablet;oral | Cyproheptadine Hydrochloride | Discontinued |
| May 8, 1990 | Supplement 23Labeling | Approved | None posted |
| May 2, 1989 | Supplement 16Labeling | Approved | None posted |
| Aug 8, 1988 | Supplement 14Labeling | Approved | None posted |
| Jul 6, 1988 | Supplement 15Labeling | Approved | None posted |
| Oct 25, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters